Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study

BACKGROUND: Combination vaccines reduce the number of pediatric injections but must be as safe, immunogenic, and effective as each of the individual vaccines given separately. Additionally, consistency in manufacturing lots is essential for WHO prequalification. This study aimed to establish the lot...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangarule, S, Prashanth, S, Kawade, A, Ravi, MD, Padmavathi, IV, Palkar, S, Tripathi, VN, Singh, R, Maurya, M, Mitra, M, Shetty, RS, Kompithra, RZ, Dhaded, SM, Epari, V, Moureau, A, Jayanth, MV, Varghese, K, Ravinuthala, S, Kukian, D, Patnaik, BN, Noriega, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508377/
https://www.ncbi.nlm.nih.gov/pubmed/36164460
http://dx.doi.org/10.1016/j.jvacx.2022.100216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508377/
https://www.ncbi.nlm.nih.gov/pubmed/36164460
http://dx.doi.org/10.1016/j.jvacx.2022.100216

Ejemplares similares